Elke K. Friedman

Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non–Small-Cell Lung Cancer

David R. Spigel, Howard A. Burris, F. Anthony Greco et al. · Journal of Clinical Oncology · 2011 · 160 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first‐line treatment of patients with glioblastoma multiforme

John D. Hainsworth, Thomas J. Ervin, Elke K. Friedman et al. · Cancer · 2010 · 126 citations

Medicine, Oncology, Pharmacotherapy +17

Prospective Clinical Validation of the InVisionFirst-Lung Circulating Tumor DNA Assay for Molecular Profiling of Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer

Michael A. Pritchett, D. Ross Camidge, Manu Patel et al. · JCO Precision Oncology · 2019 · 48 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Pazopanib in patients with metastatic renal cell carcinoma previously treated with sunitinib or bevacizumab: A Sarah Cannon Research Institute phase II trial.

James A. Reeves, David R. Spigel, Davey B. Daniel et al. · Journal of Clinical Oncology · 2011 · 17 citations

Medicine, Oncology, Pharmacology +14